Eutilex.Co.,Ltd (KOSDAQ:263050)

South Korea · Delayed Price · Currency is KRW

1,219.00

-66.00 (-5.14%)

At close: Dec 5, 2025

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
T-cell Therapy and Antibody Therapeutics	9.53B	Log In	Log In	Log In	Log In	Upgrade
T-cell Therapy and Antibody Therapeutics Growth	7136.10%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
South Korea	9.53B	Log In	Log In	Log In	Log In	Upgrade
South Korea Growth	10215.32%	Log In	Log In	Log In	Log In	Upgrade
China	-	Log In	Log In	Log In	Log In	Upgrade
China Growth	-	Log In	Log In	Log In	Log In	Upgrade